Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLC - Episode 5

EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC

Eduardo Santos, MD, FACP, FCCP, highlights key takeaways from the latest EMPOWER-LUNG03 data and discusses the impact of these findings on the treatment setting.